During tumor progression, deregulated activation of Aurora A kinase (AURKA) is functionally linked to epithelial-to-mesenchymal transition (EMT) reprogramming and expansion of a subpopulation of tumor-initiating cells harboring a CD44+/CD24low/− phenotype [10–12]. Here, CD44 is linked to neoplasm.